Hope for Families Facing Dementia: New Research Could Change Everything

By S. Ahmad Sajjadi, MD, PhD, Professor, Neurology and Pathology, School of Medicine, University of California, Irvine

Joshua D. Grill, PhD, Director, UCI MIND, Professor, Psychiatry and Human Behavior and Neurobiology and Behavior, University of California, Irvine

Dementia is among the most feared medical conditions in the world, particularly for older adults. While some changes in memory and thinking are a normal part of aging, neurodegenerative diseases such as Alzheimer's disease can lead to progressive cognitive decline that ultimately affects a person's ability to live independently.

Although Alzheimer's disease is the most common cause of dementia, it is far from the only one. Researchers now know that several diseases can cause dementia on their own or occur alongside Alzheimer's, making diagnosis and treatment more complex.

At the University of California, Irvine, UCI MIND — the Institute for Memory Impairments and Neurological Disorders — is helping lead the effort to better understand these diseases. As one of only 37 National Institute on Aging-funded Alzheimer's Disease Research Centers in the nation, UCI MIND is advancing research aimed at improving the diagnosis, treatment and prevention of all forms of dementia. 

One important focus is LATE, or limbic-predominant age-related TDP-43 encephalopathy. LATE is particularly common in adults in their 80s and 90s, the fastest-growing age groups and those most affected by dementia.

Like Alzheimer's disease, LATE causes significant memory impairment, though symptoms often progress more slowly. The two diseases frequently occur together, leading to faster cognitive decline than either condition alone. Researchers are working to answer critical questions: Why do some people develop both diseases? How can physicians distinguish LATE from Alzheimer's during life? And what treatments might slow or prevent its progression?

To address these questions, UCI MIND researchers are leading a new National Institute on Aging-funded study focused on LATE. The goal is not only to better understand this disease but also to accelerate the development of more precise diagnostic tools and future therapies.

Dementia research is entering a period of remarkable progress. Recent advances have improved scientists' ability to identify the diseases that cause dementia, and new therapies for Alzheimer's disease are beginning to change clinical care. Researchers are optimistic that similar breakthroughs for LATE and other forms of dementia will follow as scientific understanding continues to grow.

Advances like these depend on decades of careful research, collaboration and partnerships among scientists, clinicians and research participants. Each discovery helps build a clearer understanding of these complex diseases and informs the next generation of diagnostic tools and potential treatments.

As research advances, UCI MIND continues to expand its role in dementia research, bringing together scientists, clinicians and research participants to tackle some of the field's most pressing challenges. With expertise spanning Alzheimer's disease, LATE and other neurodegenerative disorders, the institute is helping shape a future in which earlier diagnosis, more effective treatments and ultimately prevention become possible for families facing dementia.